RK
Rahul Kumar Ram
About Rahul Kumar Ram
Data last updated:
Rahul Kumar Ram is a Director at Glenwin Healthcare Private Limited (since 2024) and Director at Ducwin Pharmaceuticals Private Limited (since 2018). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹1.32 Cr; the largest is Glenwin Healthcare Private Limited at ₹1.08 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Dec 2024 | 2021 | ₹1.08 Cr (FY 2024) | Active | |
| Director | 22 Nov 2018 | 2018 | ₹23.5 Lakh (FY 2020) | Active |
Board colleagues of Rahul Kumar Ram
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepti Verma | 09276860 | Glenwin Healthcare Private Limited | Director |
| Chandan Kumar | 08285020 | Ducwin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Kumar Ram
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Kumar Ram
Rahul Kumar Ram currently holds 2 directorships: Glenwin Healthcare Private Limited (Director, since 17 Dec 2024, revenue ₹1.08 Cr (FY 2024)); Ducwin Pharmaceuticals Private Limited (Director, since 22 Nov 2018, revenue ₹23.5 Lakh (FY 2020)).
Rahul Kumar Ram was first appointed on 22 Nov 2018 as Director at Ducwin Pharmaceuticals Private Limited. The most recent appointment on record is 17 Dec 2024 at Glenwin Healthcare Private Limited.
The 2 current companies of Rahul Kumar Ram that report revenue have a combined latest revenue of ₹1.32 Cr: Glenwin Healthcare Private Limited ₹1.08 Cr (FY 2024); Ducwin Pharmaceuticals Private Limited ₹23.5 Lakh (FY 2020).
The current boards of Rahul Kumar Ram's companies include Deepti Verma (Glenwin Healthcare Private Limited), Chandan Kumar (Ducwin Pharmaceuticals Private Limited).